CD274 and cancer: In recent years, immunotherapy, particularly, PD-1/PD-L1 immune checkpoint inhibitors providing a means of utilizing a patient’s own immune system to exterminate cancer cells, has demonstrated substantial benefits for many patients with advanced cancer types.